BACKGROUND: We studied the type-specific infection of human papillomavirus (HPV) at the anal canal and penile site in a cohort of HIV-infected men. METHODS: Prevalence, clearance, and incidence of specific HPV types in the anal canal and penis were determined in 733 HIV-infected men from the Spanish CAn Ruti HIV+ Men ([CARH•MEN]) cohort (538 men who have sex with men [MSM] and 195 heterosexual men). RESULTS: In both groups, the most prevalent high-risk type was HPV-16 (anal canal [31.6% MSM; 6.8% heterosexual] and penis [4.8% MSM; 6.8% heterosexual]). The most prevalent low-risk type was HPV-6 (anal canal [23.2% MSM; 12.8% heterosexual], penis [8.1% MSM; 8.9% heterosexual]). Anal prevalence was significantly higher in MSM, as was incidence, except for HPV-16, which was similar between male groups (5.9 new cases per 1000 person-months [95% confidence interval, 4.3-7.9] in MSM; 4.4 [95% confidence interval, 2.5-7.2] in heterosexual men; P > 0.05). The anal clearance rate of the different HPV types and retention time of infection were similar in both groups, as well as the HPV infection of the penis. CONCLUSIONS: HIV-infected MSM had a high prevalence of HPV infection at the anal canal; however, heterosexual HIV-infected men were also at risk for acquiring and sustaining persistent high-risk HPV types at the anal and penile site and are at risk for developing dysplasia in the future. All HIV-infected men should be recommended for routinely anal HPV screening.
BACKGROUND: We studied the type-specific infection of human papillomavirus (HPV) at the anal canal and penile site in a cohort of HIV-infectedmen. METHODS: Prevalence, clearance, and incidence of specific HPV types in the anal canal and penis were determined in 733 HIV-infectedmen from the Spanish CAn Ruti HIV+ Men ([CARH•MEN]) cohort (538 men who have sex with men [MSM] and 195 heterosexual men). RESULTS: In both groups, the most prevalent high-risk type was HPV-16 (anal canal [31.6% MSM; 6.8% heterosexual] and penis [4.8% MSM; 6.8% heterosexual]). The most prevalent low-risk type was HPV-6 (anal canal [23.2% MSM; 12.8% heterosexual], penis [8.1% MSM; 8.9% heterosexual]). Anal prevalence was significantly higher in MSM, as was incidence, except for HPV-16, which was similar between male groups (5.9 new cases per 1000 person-months [95% confidence interval, 4.3-7.9] in MSM; 4.4 [95% confidence interval, 2.5-7.2] in heterosexual men; P > 0.05). The anal clearance rate of the different HPV types and retention time of infection were similar in both groups, as well as the HPV infection of the penis. CONCLUSIONS:HIV-infected MSM had a high prevalence of HPV infection at the anal canal; however, heterosexual HIV-infectedmen were also at risk for acquiring and sustaining persistent high-risk HPV types at the anal and penile site and are at risk for developing dysplasia in the future. All HIV-infectedmen should be recommended for routinely anal HPV screening.
Authors: Han-Zhu Qian; Yifei Hu; James G Carlucci; Lu Yin; Xiangwei Li; Anna R Giuliano; Dongliang Li; Lei Gao; Yiming Shao; Sten H Vermund Journal: Sex Transm Dis Date: 2017-11 Impact factor: 2.830
Authors: G A Binda; G Gagliardi; I Dal Conte; M Verra; P Cassoni; E Cavazzoni; E Stocco; S Delmonte; P De Nardi; L Sticchi; M Mistrangelo Journal: Tech Coloproctol Date: 2019-06-26 Impact factor: 3.781
Authors: Rebecca G Nowak; Søren M Bentzen; Lisa M Schumaker; Nicholas P Ambulos; Nicaise Ndembi; Wuese Dauda; Andrew Mitchell; Trevor J Mathias; Trevor A Crowell; Stefan D Baral; William A Blattner; Manhattan E Charurat; Joel M Palefsky; Kevin J Cullen Journal: Sex Transm Dis Date: 2022-04-01 Impact factor: 2.830
Authors: Alan G Nyitray; Mihyun Chang; Luisa L Villa; Roberto J Carvalho da Silva; Maria Luiza Baggio; Martha Abrahamsen; Mary Papenfuss; Manuel Quiterio; Jorge Salmerón; Eduardo Lazcano-Ponce; Anna R Giuliano Journal: J Infect Dis Date: 2015-02-03 Impact factor: 5.226
Authors: Maarten F Schim van der Loeff; Sofie H Mooij; Oliver Richel; Henry J C de Vries; Jan M Prins Journal: Curr HIV/AIDS Rep Date: 2014-09 Impact factor: 5.071
Authors: Amelia B Thompson; Scott E Gillespie; Marina B Mosunjac; Sophia A Hussen; Lisa C Flowers; Andres F Camacho-Gonzalez Journal: J Low Genit Tract Dis Date: 2018-10 Impact factor: 1.925
Authors: Ronald B Geskus; Cristina González; Montserrat Torres; Jorge Del Romero; Pompeyo Viciana; Mar Masiá; José R Blanco; Mauricio Iribarren; Silvia De Sanjosé; Beatriz Hernández-Novoa; Marta Ortiz; Julia Del Amo Journal: AIDS Date: 2016-01-02 Impact factor: 4.177
Authors: William C Mathews; Wollelaw Agmas; Edward R Cachay; Bard C Cosman; Christopher Jackson Journal: PLoS One Date: 2014-08-07 Impact factor: 3.240
Authors: Chang Hun Lee; Sun Hee Lee; Shinwon Lee; Heerim Cho; Kye-Hyung Kim; Jung Eun Lee; Eun Ju Jung; Su Jin Lee; Eun Jung Kim; Ki Hyung Kim; Eunsoo Moon; Hong Je Cho Journal: PLoS One Date: 2016-08-22 Impact factor: 3.240